A University of Zurich spin-off, Oncobit develops a cancer monitoring platform based on detecting markers in liquid biopsies. The capital increase of more than CHF 1.9 million, with existing investors and business angels, will fund clinical validation and commercial expansion.
- Announced on
- Round
- Undisclosed round
- Amount
- CHF 1.9 M
- Location
- Schlieren, canton of Zurich
- Sector
- Health & medtech
Investors
- ID Solutions (IDS)
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic